MENU
+Compare
VERU
Stock ticker: NASDAQ
AS OF
Feb 4, 04:10 PM (EDT)
Price
$2.50
Change
-$0.06 (-2.34%)
Capitalization
41.09M

VERU Veru Inc Forecast, Technical & Fundamental Analysis

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases... Show more

VERU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for VERU with price predictions
Feb 03, 2026

Momentum Indicator for VERU turns positive, indicating new upward trend

VERU saw its Momentum Indicator move above the 0 level on February 03, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned positive. In of the 92 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for VERU just turned positive on January 02, 2026. Looking at past instances where VERU's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

VERU moved above its 50-day moving average on January 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for VERU crossed bullishly above the 50-day moving average on January 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VERU advanced for three days, in of 237 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 83 cases where VERU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

VERU broke above its upper Bollinger Band on January 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. VERU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.241) is normal, around the industry mean (27.519). P/E Ratio (0.370) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (1.788) is also within normal values, averaging (331.843).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VERU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
VERU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

VERU paid dividends on May 07, 2014

Veru Inc VERU Stock Dividends
А dividend of $0.01 per share was paid with a record date of May 07, 2014, and an ex-dividend date of April 28, 2014. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of female condoms

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Household Or Personal Care
Address
2916 North Miami Avenue
Phone
+1 305 509-6897
Employees
189
Web
https://www.verupharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CZFS66.651.29
+1.97%
Citizens Financial Services Inc
TFIN64.880.86
+1.34%
Triumph Financial Inc
ONMD0.780.01
+1.32%
OneMedNet Corp
AL64.650.06
+0.09%
Air Lease Corp
NVDA180.34-5.27
-2.84%
NVIDIA Corp

VERU and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VERU has been loosely correlated with PXXLF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if VERU jumps, then PXXLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERU
1D Price
Change %
VERU100%
-0.39%
PXXLF - VERU
37%
Loosely correlated
N/A
PRAX - VERU
35%
Loosely correlated
+0.46%
APLS - VERU
34%
Loosely correlated
+2.15%
SRRK - VERU
32%
Poorly correlated
+2.87%
COGT - VERU
32%
Poorly correlated
-1.79%
More